Bottom line
How much do XLV and JDOC overlap?
62% of their top holdings overlap by weight. 15 securities appear in both funds' top 25, making up 66.8% of XLV's assets and 55.8% of JDOC's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings XLV and JDOC have in common
| Holding | % of XLV | % of JDOC | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 16.51% | 7.76% | 7.76% |
| Johnson & Johnson | 10.64% | 4.82% | 4.82% |
| AbbVie Inc | 7.74% | 7.85% | 7.74% |
| UnitedHealth Group Inc | 6.57% | 5.85% | 5.85% |
| Merck & Co Inc | 5.52% | 4.82% | 4.82% |
| Thermo Fisher Scientific Inc | 3.24% | 3.73% | 3.24% |
| Abbott Laboratories | 2.75% | 3.11% | 2.75% |
| Intuitive Surgical Inc | 2.45% | 1.93% | 1.93% |
| CVS Health Corp | 2.30% | 2.83% | 2.30% |
| Danaher Corp | 2.09% | 2.16% | 2.09% |
| Bristol-Myers Squibb Co | 2.05% | 3.57% | 2.05% |
| Stryker Corp | 1.89% | 2.23% | 1.89% |
| Regeneron Pharmaceuticals Inc | 1.08% | 1.60% | 1.08% |
| Cardinal Health Inc | 0.97% | 1.51% | 0.97% |
| Cencora Inc | 0.96% | 2.07% | 0.96% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in XLV
- Amgen Inc — 3.40%
- Gilead Sciences Inc — 2.73%
- Pfizer Inc — 2.39%
- Vertex Pharmaceuticals Inc — 2.19%
- Medtronic PLC — 1.75%
- McKesson Corp — 1.58%
- Elevance Health Inc — 1.46%
- Cigna Group/The — 1.27%
- Boston Scientific Corp — 1.10%
- HCA Healthcare Inc — 1.05%
Only in JDOC
- AstraZeneca plc — 3.76%
- Roche Holding AG — 2.82%
- Novo Nordisk A/S — 2.61%
- GSK plc — 2.47%
- Argenx SE — 2.06%
- Edwards Lifesciences Corp. — 1.73%
- IQVIA Holdings, Inc. — 1.71%
- Teva Pharmaceutical Industries Ltd. — 1.60%
- Novartis AG — 1.60%
- Biogen, Inc. — 1.56%
Asset mix
| Asset type | XLV | JDOC |
|---|---|---|
| Stocks | 99.7% | 99.2% |
| Cash & short-term funds | 0.3% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | XLV | JDOC |
|---|---|---|
| US | 97.9% | 75.2% |
| GB | — | 6.2% |
| CH | — | 4.4% |
| DK | — | 4.0% |
| JP | — | 2.5% |
| NL | — | 2.4% |
| IE | 2.1% | 0.4% |
| DE | — | 1.9% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do XLV and JDOC overlap?
What stocks do XLV and JDOC have in common?
Should I own both XLV and JDOC?
Which holds more stocks, XLV or JDOC?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.